Found 7 matching trials
A Study of TAK-881 and HyQvia in Healthy Adults
PHASE1The main aim of this study is to understand how the body absorbs, processes...
Expanded Access to TAK-881 for People With Primary Immunodeficiency Diseases in the USA and Czech Republic
N/AThe expanded access program allows people to gain access to an unlicensed t...
Location
Multiple Locations
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
PHASE3The main aim of this study is to evaluate the pharmacokinetic (PK) comparab...
Location
HonorHealth Neurology
A Study of TAK-881 in Healthy Adults
PHASE1The main aims of this study are to check for side effects from TAK-881 in h...
Location
Clinical Pharmacology of Miami
A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases
PHASE2The main aim of this study is to evaluate the PK, safety, tolerability and ...
Location
University of California Irvine Medical Center
A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy Adults
PHASE1The main aim of this study is to check how well healthy adults can tolerate...
A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases
PHASE3The main aim of this study is to learn if TAK-881 is safe and well tolerate...
Status
Active Not Recruiting
Location
University of California, Irvine Medical Sciences I